SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-177095
Filing Date
2020-06-24
Accepted
2020-06-24 07:48:01
Documents
5
Period of Report
2020-06-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d949145d8k.htm 8-K 40945
2 EX-2.1 d949145dex21.htm EX-2.1 712898
3 EX-10.1 d949145dex101.htm EX-10.1 100510
4 EX-10.2 d949145dex102.htm EX-10.2 65700
5 EX-10.3 d949145dex103.htm EX-10.3 46652
  Complete submission text file 0001193125-20-177095.txt   967822
Mailing Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121
Business Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36282 | Film No.: 20983882
SIC: 2836 Biological Products, (No Diagnostic Substances)